Back to Search
HECTOR PRETI, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1861484628IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
103672-875(WI)036158567(IL)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Research & Publications (7)
Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.
PMID 19608275·Leuk Res·2010
8-other
Prognostic impact of C-REL expression in diffuse large B-cell lymphoma.
PMID 19669219·J Hematop·2009
8-other
Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease.
PMID 16625103·Am J Surg Pathol·2006
5-case
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha.
PMID 15741224·Blood·2005
3-trial
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
PMID 12942571·Cancer·2003
3-trial
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
PMID 11521796·Ann Oncol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
Via practice · 2 locations total
- Address
- 5841 S MARYLAND AVE
CHICAGO, IL 60637 - Phone
- (773) 702-1000
Quick Facts
- NPI
- 1861484628
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Publications
- 7
Are you this provider?
Claim Your Profile